tirzepatide suomi Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial Tirzepatide Treatment | Longevity Direct

Lose 15% of your body weight with GLP-1s * Lose 15% of your body weight with GLP-1s * *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, the treatment group receiving semaglutide experienced a mean body weight loss of 15%, compared to 2% of the placebo group

8 weeks (1 vial): 3 mL 1 10 mL bottle 12 weeks (2 vials): 6 mL 1 10 mL bottle 16 weeks (4 vials): 12 mL 2 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each administration day

Only increase to 12.5-15mg if weight loss stalls

Add 2 mL, you get 5 mg/mL

Studies have indicated that weight management can significantly improve insulin sensitivity and overall metabolic health, which is crucial for pregnant women who may be at risk for gestational diabetes